HTRS Hosts Webinar: Novel Therapies In VWD And Rare Bleeding Disorders
Hemostasis & Thrombosis Research Society (HTRS) posted on LinkedIn:
”Join HTRS for our upcoming educational webinar: “Novel Therapies in VWD and Rare Bleeding Disorders” on Tuesday, October 21 at 3:00PM EST.
Discover the latest advances in treatment and research for von Willebrand disease (VWD) and rare bleeding disorders with two renowned experts:
Dr. Debbie Jiang – Adult classical hematologist at Massachusetts General Hospital and the Boston Bleeding Disorders Center. A recipient of the HTRS/Novo Nordisk Clinical Scholar Award, Dr. Jiang is dedicated to advancing care and research for bleeding and clotting disorders.
Dr. Stacy Croteau – Pediatric hematologist and clinical researcher at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. As Medical Director of the Boston Bleeding Disorders Center and National Chair of the ATHN/NHPCC Transition Working Group, Dr. Croteau leads efforts to improve outcomes and transitions of care for individuals with bleeding disorders.
Don’t miss this opportunity to hear directly from leaders shaping the future of bleeding disorder care. Register now to secure your spot.”
Stay updated with Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action